23andMe Investor Presentation Deck

Potential to use Genetics to More Efficiently Develop Novel Therapeutics by "Power, Need, and Speed" 1. IND Investigational New Drug Application. fdareview.org, "The Drug Development and Approval Process" (2020). 2. Probability of success for a drug to be approved is estimated to be <12%. 3. PhRMA, "Biopharmaceutical Research & Development: The Process Behind New Medicines" (2015). Drug Development is Inefficient 7 years average time-to-IND¹ $2.6B average cost of drug development³ Copyright © 2023 23and Me, Inc. ~90% failure rate², 3 23andMe 28

View entire presentation